RYTM: Rhythm Pharmaceuticals Inc. Company Profile & Statistics

About

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies which result in life-threatening metabolic disorders. The Company's product candidate principally consists of setmelanotide, a potent, first-in-class melanocortin-4 receptor or MC4R, agonist for the treatment of rare genetic disorders of obesity. Rhythm Pharmaceuticals, Inc. is based in Boston, MA.

Info & Links

CEO

David P. Meeker

Headquarters

222 BERKELEY STREET, 12TH FLOOR
BOSTON, MA 02116, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

226

Rhythm Pharmaceuticals Inc. Statistics

Valuation Measures

Market Capitalization²

3.30B

Enterprise Value

3.26B

Enterprise Value/EBITDA(ttm)

-12.99

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

30.17

Price to Book(mrq)

301.12

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

88.55%

Operating Margin(ttm)

-230.07%

Profit Margin(ttm)

-241.72%

Return on Equity(ttm)

-367.36%

Return on Invested Capital(ttm)

-300.65%

Return on Assets(ttm)

-77.47%

Income Statement

Revenue(ttm)

112.53M

Revenue Per Share(ttm)

1.83

Gross Profit(ttm)

99.72M

EBITDA(ttm)³

-250.56M

Net Income Available to Common(ttm)

-261.54M

Diluted EPS(ttm)

-4.33

Share Statistics

Beta (5Y Monthly)

2.14

52-Week Change

54.65%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

61.46M

Dividend Yield

0.00%

Float⁴

58.02M

% Held by Insiders

5.60%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

298.39M

Total Cash Per Share(mrq)

4.86

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.49%

Quick Ratio(mrq)

3.34%

Book Value Per Share(mrq)

2.49

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.55

Free Cash Flow(ytd)

-135.53M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

RYTM

Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc. Profile